<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01771419</url>
  </required_header>
  <id_info>
    <org_study_id>H San Paolo</org_study_id>
    <nct_id>NCT01771419</nct_id>
  </id_info>
  <brief_title>Comparison Of Loop-Tip Wire Vs Tradictional Technique In The Cannulation Of The Common Bile Duct</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital San Paolo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital San Paolo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Selective cannulation of common bile duct (CBD) by insertion of a guide-wire seems to be
      associated with fewer complications and post-ERCP (Endoscopic retrograde
      cholangiopancreatography) pancreatitis (PEP) rate than the conventional biliary tree access
      with cannulotome (CT-25 Cook Medical) with contrast injection even if results are
      conflicting. the aim of our study is to test a new guide-wire (loop-tip wire), with a loop in
      the tip, for the prevention of PEP and biliary tree access, in PEP high-risk patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post ERCP pancreatitis rate</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>participants will be followed for the duration of hospital stay, an expected average of 2 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of attempts to obtain the cannulation of CBD and number of participants with adverse events as a measure of safety and tolerability</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>participants will be followed for the duration of hospital stay, an expected average of 2 weeks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Post-ERCP Pancreatitis</condition>
  <arm_group>
    <arm_group_label>loop-tip arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The cannulation of CBD will be obtained using the loop-tip wire (Cook Medical inc.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The cannulation of CBD will be obtained with a Cook Medical sphincterotome CT-25 mm (tradictional technique)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Loop-tip wire (Cook Medical) for the cannulation of the CBD</intervention_name>
    <arm_group_label>loop-tip arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cannulotome CT-25mm Cook Medical</intervention_name>
    <arm_group_label>Control arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  high-risk patients for post-ERCP pancreatitis

        Exclusion Criteria:

          -  age &lt; 18 years

          -  allargy to the contrast medium

          -  previous biliary or gastric surgery

          -  neoplastic patients

          -  previous biliary or pancreatic sphincterotomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>San Paolo Hospital</name>
      <address>
        <city>Milan</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benedetto Mangiavillano, MD</last_name>
      <phone>0039 02 8184</phone>
      <phone_ext>4273</phone_ext>
      <email>b_mangiavillano@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2013</study_first_submitted>
  <study_first_submitted_qc>January 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2013</study_first_posted>
  <last_update_submitted>January 16, 2013</last_update_submitted>
  <last_update_submitted_qc>January 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital San Paolo</investigator_affiliation>
    <investigator_full_name>Benedetto Mangiavillano</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>loop-tip</keyword>
  <keyword>ERCP</keyword>
  <keyword>cannulation of CBD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 4, 2016</submitted>
    <returned>April 1, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

